Poseida Therapeutics, Inc. Employee-related Liabilities, Current
Poseida Therapeutics, Inc. had Employee-related Liabilities, Current of $9.32 million as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:EmployeeRelatedLiabilitiesCurrent · last filed 2024-11-07
- 2024-09-30: Employee-related Liabilities, Current $9.32M.
- 2024-06-30: Employee-related Liabilities, Current $7.88M.
- 2024-03-31: Employee-related Liabilities, Current $5.22M.
- 2023-12-31: Employee-related Liabilities, Current $13.08M.
| Period end | Employee-related Liabilities, Current |
|---|---|
| 2024-09-30 | $9.32M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $7.88M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $5.22M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $13.08M 10-Q · filed 2024-11-07 |
| 2023-09-30 | $8.63M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $6.86M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $5.10M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $11.27M 10-K · filed 2024-03-07 |
| 2022-09-30 | $7.50M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $6.00M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $4.38M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $8.76M 10-K · filed 2023-03-09 |
| 2021-09-30 | $5.86M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $4.68M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $3.32M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $6.79M 10-K · filed 2022-03-10 |
| 2020-09-30 | $4.82M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $3.14M 10-Q · filed 2020-08-20 |
| 2019-12-31 | $3.28M 10-K · filed 2021-03-11 |